Kura Oncology (KURA) Tops Q1 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q1 EPS of ($0.50), $0.04 better than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Morgan Stanley Starts Adani Enterprises Ltd. (ADE:IN) at Overweight
• Morgan Stanley upgrades CDW on stronger AI-driven server demand